WHO ICTRP trial
A clinical trial of Wei Bi Formula for treating "Wei Zheng Syndrome" cervical…
ITMCTR2025000334 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2025000334 |
|---|---|
| Public title | A clinical trial of Wei Bi Formula for treating "Wei Zheng Syndrome" cervical spondylotic myelopathy. |
| Scientific title | A clinical trial of Wei Bi Fang for treating "Wei Zheng type" cervical spondylotic myelopathy. |
| Primary sponsor | Longhua Hospital Shanghai University of Traditional Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Pilot clinical trial |
| Countries | The People's Republic of China |
| Conditions | cervical spondylotic myelopathy |
| Interventions | comparison group: Placebo treatment 4 sachets/dose, 2 times/day, taken orally after breakfast, lunch and dinner for 8 weeks.;treatment group:Wibi Formula 4 sachets/times 2 times/day taken orally after breakfast lunch and dinner for a… |
| Registration date | Feb 18, 2025 |
| Target size | comparison group:40;treatment group:40 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: